Your session is about to expire
← Back to Search
Behavioural Intervention
MPACT Program for Opioid Use Disorder (MPACT Trial)
N/A
Waitlist Available
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Patients receiving methadone treatment at the enrolled opioid treatment programs
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
No Placebo-Only Group
Summary
"This trial will study how a new program called MPACT affects patients receiving methadone treatment. It will look at whether the program helps patients stay in treatment and reduces the risk of overdose. The trial
Who is the study for?
This trial is for staff members who provide methadone treatment services at opioid treatment programs. It's not open to patients currently receiving methadone treatment at these facilities.
What is being tested?
The MPACT intervention is being tested to see if it helps with keeping patients on methadone treatment and reduces overdoses while in treatment. The study will also look into how trauma symptoms affect the implementation of this program.
What are the potential side effects?
Since this trial focuses on the implementation of a service (MPACT) rather than a drug, traditional side effects are not applicable. However, there may be impacts related to changes in clinic practices or staff workload.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently receiving methadone treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Days in Treatment to treatment interruption
In Treatment- Point in time
Number of patients reporting opioid overdoses while in methadone treatment
+1 moreSecondary study objectives
Number of patients and staff experiencing post traumatic stress symptoms
Number of staff experiencing vicarious (work related) stress
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: MPACT InterventionExperimental Treatment1 Intervention
Enrolled clinic staff will be exposed to the MPACT intervention components over the trial period. This includes accredited training, clinic self assessment, reflective supervision for counseling/peer/case management staff, and wellness education with navigation to trauma symptoms assessment and resources including trauma treatment. Periodic surveys of staff and patients will be conducted to assess outcome measures (primary and secondary) and patient chart reviews will verify patient outcomes.
Group II: Control for MPACTActive Control1 Intervention
Enrolled clinic staff will not receive any portion of the intervention. Periodic surveys of staff and patients will be conducted to assess outcome measures (primary and secondary) and patient chart reviews will verify patient outcomes.
Find a Location
Who is running the clinical trial?
University of ArizonaLead Sponsor
538 Previous Clinical Trials
160,377 Total Patients Enrolled
1 Trials studying Patients
140 Patients Enrolled for Patients